HDAC6 inhibitors and their uses
US-10106540-B2 · Oct 23, 2018 · US
US9181237B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9181237-B2 |
| Application number | US-201414504906-A |
| Country | US |
| Kind code | B2 |
| Filing date | Oct 2, 2014 |
| Priority date | Oct 4, 2013 |
| Publication date | Nov 10, 2015 |
| Grant date | Nov 10, 2015 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention provides substituted berbines, processes for the synthesis of substituted berbine compounds, as well as intermediates used in the synthesis of substituted berbine compounds. Also provided are methods for using the substituted berbines to inhibit cancer cell growth.
Opening claim text (preview).
What is claimed is: 1. A compound of Formula (V-1): wherein: R 1 R 2 , R 3 , and R 4 independently are hydrogen, halogen, OR 15 , NR 15 N 16 , nitro, cyano, thiol, hydrocarbyl, substituted hydrocarbyl, or together R 2 and R 3 along with the ring carbons to which they are attached form a ring comprising {—}O(CH 2 ) n O{—}; R 5 , R 6 , R 7 , and R 8 independently ar…
Chemistry & Metallurgy · mapped topic
Related publications grouped by family.
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Answers are generated from the same data shown on this page.